We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer to Purchase Sickle Cell Drugmaker Global Blood Therapeutics
Pfizer to Purchase Sickle Cell Drugmaker Global Blood Therapeutics
Pfizer announced that it will pay $5.4 billion for Global Blood Therapeutics (GBT), manufacturer of Oxbryta (voxelotor), one of a handful of drugs for treating sickle cell anemia.
